The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s drugs of abuse DOA testing market report forecasts the drugs of abuse DOA testing market size to grow to $9.35 Billion by 2027, with a CAGR (compound annual growth rate) of almost 9%.

Learn More On The Drugs Of Abuse DOA Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

Drugs Of Abuse DOA Testing Market Size Forecast
The global drugs of abuse DOA testing market is expected to grow from $6.03 billion in 2022 to $6.65 billion in 2023 at a compound annual growth rate (CAGR) of 10.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The global drug of abuse (DOA) testing market size is expected to reach $9.35 billion in 2027 at a CAGR of 8.9%.

North America held the largest drugs of abuse DOA testing market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Drugs Of Abuse DOA Testing Market Driver ­– Increase In Demand For Drug Abuse Treatment
For example, according to the United Nations Office on Drugs and Crime (UNODC), a US-based drug control and crime prevention organisation, in June 2021, over 36 million people worldwide have drug use disorders, and over 275 million people used drugs in 2020, combining the United Nations International Report 2021 World Drug Report. As a result, the growing need for drug addiction therapy is propelling the drug of abuse (DOA) testing market.

Request for A Sample Of The Global Drugs Of Abuse DOA Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9381&type=smp

Key Drugs Of Abuse DOA Testing Market Trend – Technological Advancement
Major players in the drugs of abuse (DOA) testing industry are focusing on developing new technical solutions to increase their market position. For example, in May 2020, a Canadian technology company developed tools for law enforcement to detect THC in breath. Cannabix Technologies’ point-of-care breath testing technologies are at the forefront of industry research and development for the detection of 9-tetrahydrocannabinol (“THC”), the psychoactive ingredient in marijuana that contributes to impairment. THC in breath is detected by the THCBA employing microfluidic sensor technology. The THCBA has appealing characteristics like single-stage direct breathing and a one-handed ergonomic design. So far, testing has revealed that the device can deliver results in less than 5 minutes after the sample is consumed.

Drugs Of Abuse DOA Testing Market Segment
1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services
2) By Sample Type: Urine, Hair, Oral Fluid, Breath
3) By Application: Pain Management, Criminal Justice, Workplace Screening
4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users

Drugs Of Abuse DOA Testing Market Major Players and Strategies
Major players in the drugs of abuse DOA testing market are Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Dragerwerk AG & Co. KGaA, Quest Diagnostics Inc., United States Drug Testing Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd, Cordant Health Solutions, Omega Laboratories Inc., Psychemedics Corporation, Zimmer Biomet, Homology Medicines Inc., and bioMérieux Inc.

Medix Biochemica, a biotechnology business based in Finland, paid an undisclosed sum for Biostride Inc. in June 2020. Biostride’s collection of drug of abuse antibodies and antigens is now available to IVD and drug testing customers globally as a result of this acquisition. The acquisition is in line with Medix’s strategy to streamline the IVD supply chain and become the industry’s leading provider of critical raw materials. Biostride Inc. is a company established in the United States that manufactures antibodies and antigens for the IVD sector for drug testing and hormone testing.

The Drugs Of Abuse DOA Testing Global Market Report 2023 covers regional data on drugs of abuse DOA testing market size, drugs of abuse DOA testing market trends and drivers, opportunities, strategies, and drugs of abuse DOA testing market competitor analysis. The countries covered in the drugs of abuse DOA testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

DOA testing is the evaluation of a substance, such as a drug, chemical, or plant product, that is commonly used recreationally. Marijuana, cocaine, opioids, amphetamines, alcohol, and PCP are among the drugs tested for in a drug panel. This clinical screening process makes use of the patient’s urine, saliva, blood, hair, or perspiration.

View More Reports Related To The Drugs Of Abuse DOA Testing Market –
DOAS Global Market Report 2023
Drugs For Benign Prostatic Hypertrophy Global Market Report 2023
Testing, Inspection, And Certification Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: